I’m interested to know if anyone is aware of research associated with hypercalcemia in patient's with long standing Hashimoto’s disease such that the thyroid has atrophied. I
It is my thought that
Calcitonin is produced in the Thyroid C cells are considered as the primary origin of circulating calcitonin.
An atrophied thyroid to the point that it is non-resectable will therefore not produce calcitonin at a normal level if at all.
(what is the effect of an atrophied thyroid on C cell production of calcitonin?)
The three main functions of calcitonin are: i) To absorb calcium into the bones; ii) to inhibit calcium reuptake in the kidneys; and iii) to inhibit calcium reuptake in the small intestine.
If this is the case, then my thought is that I have an underproduction of Calcitonin, which have contributed to the non-absorption of Calcium into the bones, leading to the osteopenia and consequently high end normal and/or high serum calcium levels.
Calcitonin is currently FDA-approved for treating postmenopausal osteoporosis, provided the patient has been in the postmenopausal phase for a minimum of 5 years. It inhibits osteoclasts activity.(Aug 17, 2023
what if any are the current clinical recommendations for hypercalcemia secondary to Hashimotis thyroiditis ( if in fact an association/cause/effect) has been found.
Thank you for your time and assistance with this query.